Tuberculosis (TB) is among the top 10 causes of global child mortality, and children are at highest risk of developing the disease within the first few years of life. One hypothesis for this increased risk of TB early in ...
Nov 17, 2021
0
22
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that individuals affected by mental illnesses including depression and ...
Jul 1, 2021
0
2
The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study, scientists report in The American Journal of Pathology that infection with a specific coronavirus strain ...
Jun 16, 2021
0
11
Two new studies have cast unprecedented light on disease processes in tuberculosis, identifying key genetic changes that cause damage in the lungs and a drug treatment that could speed up recovery.
Jun 15, 2021
0
12
Researchers at Tulane University School of Medicine have developed a highly sensitive blood test that can find traces of the bacteria that causes tuberculosis (TB) in infants a year before they develop the deadly disease, ...
May 18, 2021
0
6
The immune response to tuberculosis (TB) differs in adults and newborn babies due to the way immune cells use energy to kick into gear in a bid to kill the bacteria. This fresh discovery—just published in leading journal, ...
Apr 13, 2021
0
3
Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.
Mar 11, 2021
0
4
Research has found fidaxomicin, an antibiotic usually used to treat bowel infections, prevents growth of resistant strains of Mycobacterium tuberculosis (MTb) in the lab.
Feb 17, 2021
0
3
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Nov 24, 2020
0
4
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted ...
Sep 29, 2020
0
3
